BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11006030)

  • 1. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for functional ovarian cysts.
    Parazzini F; Moroni S; Negri E; La Vecchia C; Dal Pino D; Ricci E
    Epidemiology; 1996 Sep; 7(5):547-9. PubMed ID: 8862991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and risk of endometrial cancer: results from an Italian case-control study.
    Parazzini F; La Vecchia C; Negri E; Moroni S; Chatenoud L
    Gynecol Oncol; 1995 Feb; 56(2):195-9. PubMed ID: 7896185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
    Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
    Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
    Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
    Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for deep endometriosis: a comparison with pelvic and ovarian endometriosis.
    Parazzini F; Cipriani S; Bianchi S; Gotsch F; Zanconato G; Fedele L
    Fertil Steril; 2008 Jul; 90(1):174-9. PubMed ID: 18023442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
    Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
    Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic inflammatory disease and risk of ovarian cancer.
    Parazzini F; La Vecchia C; Negri E; Moroni S; dal Pino D; Fedele L
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):667-9. PubMed ID: 8824371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of invasive vulvar cancer risk: an Italian case-control study.
    Parazzini F; La Vecchia C; Garsia S; Negri E; Sideri M; Rognoni MT; Origoni M
    Gynecol Oncol; 1993 Jan; 48(1):50-5. PubMed ID: 8423022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
    Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
    Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of estrogen replacement therapy use in northern Italy.
    Parazzini F; La Vecchia C; Negri E; Bianchi C; Fedele L
    Rev Epidemiol Sante Publique; 1993; 41(1):53-8. PubMed ID: 8465065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
    Zhang M; Xie X; Holman CD
    Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for ovarian cancer histotypes.
    Chiaffarino F; Parazzini F; Bosetti C; Franceschi S; Talamini R; Canzonieri V; Montella M; Ramazzotti V; Franceschi S; La Vecchia C
    Eur J Cancer; 2007 May; 43(7):1208-13. PubMed ID: 17376671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.